Related Experiment Video
Updated: Aug 4, 2026
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
New insights into the genetics of multiple sclerosis
Sergio E Baranzini1, Jorge R Oksenberg, Stephen L Hauser
1Department of Neurology, San Francisco School of Medicine, University of California, 94143, USA.
Abstract:
Tissue injury in multiple sclerosis (MS) results from an abnormal immune response to one or more myelin antigens that develop in genetically susceptible individuals after exposure to a causal agent that is yet undefined. The genetic component of MS etiology is believed to result from the action of several genes of moderate effect. The incomplete penetrance of MS susceptibility alleles probably reflects interactions with other genes, posttranscriptional regulatory mechanisms, and significant environmental influences. Equally significant is that genetic heterogeneity also likely exists, meaning that specific genes influence susceptibility and pathogenesis in some affecteds but not in others. Some loci may be involved in the initial pathogenic events, while others could influence the development and progression of the disease. The past few years have seen significant progress in the developments of laboratory and analytical approaches to study non-Mendelian complex genetic disorders and to define the pathological basis of demyelination. These developments have set the stage for the final characterization of the genes involved in MS susceptibility and pathogenesis. The identification and characterization of the genes are likely to define the basic etiology of the disease, improve risk assessment, and influence therapeutics.
Insights
Multiple sclerosis (MS) involves genetic susceptibility and environmental factors triggering an abnormal immune response to myelin. Identifying causative genes is crucial for understanding MS etiology, improving risk assessment, and developing new therapies.
Area of Science:
- Neuroimmunology
- Genetics of complex diseases
Background:
- Multiple sclerosis (MS) pathogenesis involves an abnormal immune response targeting myelin in genetically susceptible individuals.
- The genetic basis of MS is complex, likely involving multiple genes with moderate effects and interactions with environmental factors.
- Genetic heterogeneity suggests specific genes influence susceptibility and disease progression in distinct patient subgroups.
Purpose of the Study:
- To characterize the genetic factors contributing to MS susceptibility and pathogenesis.
- To leverage advancements in genetic analysis for complex disorders to understand demyelination.
- To lay the groundwork for identifying specific genes involved in MS etiology.
Main Methods:
- Utilizing advanced laboratory and analytical approaches for studying non-Mendelian complex genetic disorders.
- Investigating the pathological basis of demyelination through genetic analysis.
- Characterizing gene loci associated with initial pathogenic events and disease progression.
Main Results:
- Progress has been made in developing methodologies for studying MS genetics.
- The groundwork is established for the comprehensive characterization of genes implicated in MS.
- Understanding genetic contributions to susceptibility and pathogenesis is advancing.
Conclusions:
- Gene identification is pivotal for defining MS etiology.
- Characterizing causative genes will enhance risk assessment for MS.
- Insights into MS genetics are expected to guide therapeutic strategies.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
01:19Multiple Sclerosis l: Introduction